The Campbell's Company
CPB Mid CapConsumer Defensive · Packaged Foods
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
The Campbell's Company en bref
The Campbell's Company (CPB) is currently trading at 18,44 € with a market capitalization of 5,5 Md €. The trailing P/E ratio stands at 10.37x, with a forward P/E of 10.69x. The 52-week range spans from 17,05 € to 29,79 €; the current price is 38.1% below the yearly high. Year-over-year revenue growth stands at -4.4%. The net profit margin stands at 6.12%.
💰 Dividende
The Campbell's Company pays an annual dividend of 1,36 € per share, representing a yield of 7.38%. The payout ratio stands at 76.47%.
📊 Avis des analystes
18 analystes évaluent The Campbell's Company (CPB) au consensus : Conserver. L'objectif de cours moyen est de 18,69 €, soit un potentiel de +1.39% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 12,20 € à 48,82 €.
The Campbell's Company : la thèse d'investissement en détail
The Campbell's Company (CPB) operates in the Consumer Defensive — specifically Packaged Foods — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
Earnings growth of 86.4% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.
Le scénario baissier
Revenue is contracting at -4.4% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Short interest sits at 31.56% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.
Valorisation en contexte
With a PEG ratio of 0.72, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity. The EV/EBITDA multiple of 7.88x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.
À surveiller
- The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
Thèse d'investissement : forces et faiblesses
- Rentabilité élevée des capitaux propres (15.39% ROE)
- Actuellement jugée sous-évaluée
- Rendement du dividende solide de 7.38%
- Free cash flow positif
- –CA en contraction (-4.4% sur un an)
- –Endettement élevé (D/E 182.03)
- –Positions vendeuses élevées (31.56%)
Aperçu technique
The price is in a transition zone relative to the moving averages — no clear signal.
Profil de risque
The data points to relatively defensive market behavior, elevated short interest (31.56%), higher leverage relative to equity.
Trading Data
💵 Dividend Info
Related Stocks in the Same Sector
More Consommation de Base stocks
Top peers in the same sector — ranked by market cap.
Where can I buy The Campbell's Company?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news